Itraconazole-enhanced chemotherapy toxicity in a patient with Hodgkin lymphoma

Journal of Pediatric Hematology/Oncology

Volumn 28, Issue 1, 2006, Pages 33-35

  Bashir, Hamid ^a   Motl, Susannah ^a   Metzger, Monika L ^b   Howard, Scott C ^b   Kaste, Sue ^b   Krasin, Matthew P ^b   Hudson, Melissa M ^b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Cytochrome P450; Doxorubicin; Drug interaction; Itraconazole; Methotrexate; P glycoprotein; Toxicity; Vinblastine

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 INHIBITOR; DOXORUBICIN; GLYCOPROTEIN P INHIBITOR; ITRACONAZOLE; METHOTREXATE; PREDNISONE; VINBLASTINE; VINCA ALKALOID; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

ADOLESCENT; ARTICLE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CASE REPORT; DISEASE COURSE; DISEASE EXACERBATION; DRUG METABOLISM; DRUG WITHDRAWAL; ENZYME INHIBITION; HISTOPLASMOSIS; HODGKIN DISEASE; HUMAN; MALE; NEUROTOXICITY; PRIORITY JOURNAL; TOXICITY; DRUG INTERACTION; FEMALE;

ADOLESCENT; ANTIBIOTICS, ANTINEOPLASTIC; ANTIFUNGAL AGENTS; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DOXORUBICIN; DRUG INTERACTIONS; FEMALE; HODGKIN DISEASE; HUMANS; ITRACONAZOLE; METHOTREXATE; PREDNISONE; VINBLASTINE;

EID: 33644834605     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Bohme A, Ganser A, Hoelzer D. Aggravation of vincristine-induced neurotoxicity by itraconazole in the treatment of adult ALL. Ann Hematol. 1995;71:311-312.
2. Repetto L. Greater risks of chemotherapy toxicity in elderly patients with cancer. J Support Oncol. 2003;1(4 Suppl 2):18-24.
3. Donaldson SS, Hudson MM, Lamborn KR, et al. VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin's disease: results of a prospective clinical trial. J Clin Oncol. 2002;20:3081-3087.
4. McGuire SA, Gospe SM Jr, Dahl G. Acute vincristine neurotoxicity in the presence of hereditary motor and sensory neuropathy type I. Med Pediatr Oncol. 1989;17:520-523.
5. Jeng MR, Feusner J. Itraconazole-enhanced vincristine neurotoxicity in a child with acute lymphoblastic leukemia. Pediatr Hematol Oncol. 2001;18:137-142.
6. Sathiapalan RK, El-Solh H. Enhanced vincristine neurotoxicity from drug interactions: case report and review of literature. Pediatr Hematol Oncol. 2001;18:543-546.
7. Kamaluddin M, McNally P, Breatnach F, et al. Potentiation of vincristine toxicity by itraconazole in children with lymphoid malignancies. Acta Paediatr. 2001;90:1204-1207.
8. Chan JD. Pharmacokinetic drug interactions of vinca alkaloids: summary of case reports. Pharmacotherapy. 1998;18:1304-1307.
9. Kivisto KT, Kroemer HK, Eichelbaum M. The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions. Br J Clin Pharmacol. 1995;40:523-530.
10. Miyama T, Takanaga H, Matsuo H, et al. P-glycoprotein-mediated transport of itraconazole across the blood-brain barrier. Antimicrob Agents Chemother. 1998;42:1738-1744.
11. Takara K, Tanigawara Y, Komada F, et al. Cellular pharmacokinetic aspects of reversal effect of itraconazole on P-glycoprotein-mediated resistance of anticancer drugs. Biol Pharm Bull. 1999;22:1355-1359.
12. Agarwal P, Chavarkar M, Parelkar S, et al. Vincristine induced right vocal cord palsy in a case of non-Hodgkin's lymphoma: a case report. J Indian Assoc Pediatr Surg. 2002;7:202-204.
13. Authier N, Gillet JP, Fialip J, et al. A new animal model of vincristine-induced nociceptive peripheral neuropathy. Neurotoxicology. 2003;24:797-805.
14. Sporanox package insert. Titusville, NJ: Janssen Pharmaceutica Products, 2004.
15. Hoagland HC, Gastineau DA. Hematologic complications of cancer chemotherapy. In: MC P, ed. The Chemotherapy Source Book. Baltimore: Williams & Wilkins, 1996:559-570.
16. Iida N, Takara K, Ohmoto N, et al. Reversal effects of antifungal drugs on multidrug resistance in MDR1-overexpressing HeLa cells. Biol Pharm Bull. 2001;24:1032-1036.
17. Kurosawa M, Okabe M, Hara N, et al. Reversal effect of itraconazole on Adriamycin and etoposide resistance in human leukemia cells. Ann Hematol. 1996;72:17-21.
18. Taflin C, Izzedine H, Launay-Vacher V, et al. Vincristine-induced severe SIADH: potentiation with itraconazole. Cancer Therapy. 2004;2:149-151.